Drug research startup Bugworks raises $9 million in Series A
Bengaluru and US-based drug research startup Bugworks Research has raised $9 million in Series A funding led by University of Tokyo Edge Capital (UTEC). The round also saw participation from Acquipharma Holdings and 3ONE4 Capital. Founded in 2014, Bugworks is working on developing ways to fight bacterial drug resistance and take its drugs to clinical trials. 